Sign inGet started

Unkart Edward W

Insider CIK 1306267 · CBYL Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
KALV KalVista Pharmaceuticals, D To issuer deriv2026-06-112026-06-1110,000— $00SEC↗
KALV KalVista Pharmaceuticals, D To issuer deriv2026-06-112026-06-1112,000— $00SEC↗
KALV KalVista Pharmaceuticals, D To issuer deriv2026-06-112026-06-116,000— $00SEC↗
KALV KalVista Pharmaceuticals, D To issuer deriv2026-06-112026-06-1130,000— $00SEC↗
KALV KalVista Pharmaceuticals, D To issuer deriv2026-06-112026-06-1110,000— $00SEC↗
KALV KalVista Pharmaceuticals, D To issuer deriv2026-06-112026-06-1110,000— $00SEC↗
KALV KalVista Pharmaceuticals, D To issuer deriv2026-06-112026-06-1110,000— $00SEC↗
KALV KalVista Pharmaceuticals, D To issuer deriv2026-06-112026-06-117,000— $00SEC↗
KALV KalVista Pharmaceuticals, D To issuer deriv2026-06-112026-06-117,000— $00SEC↗
KALV KalVista Pharmaceuticals, D To issuer deriv2026-06-112026-06-117,000— $00SEC↗
KALV KalVista Pharmaceuticals, A Award deriv2025-10-012025-10-0230,000— $030,000SEC↗
KALV KalVista Pharmaceuticals, A Award deriv2024-10-032024-10-0410,000— $010,000SEC↗
KALV KalVista Pharmaceuticals, A Award deriv2023-09-262023-09-2810,000— $010,000SEC↗
KALV KalVista Pharmaceuticals, A Award deriv2022-10-132022-10-1710,000— $010,000SEC↗
KALV KalVista Pharmaceuticals, A Award deriv2021-09-302021-10-0110,000— $010,000SEC↗
KALV KalVista Pharmaceuticals, A Award deriv2020-10-012020-10-027,000— $07,000SEC↗
KALV KalVista Pharmaceuticals, A Award deriv2019-10-022019-10-037,000$11.21 $78.5K7,000SEC↗
KALV KalVista Pharmaceuticals, A Award deriv2018-10-032018-10-057,000— $07,000SEC↗
KALV KalVista Pharmaceuticals, A Award deriv2017-09-272017-09-296,000— $06,000SEC↗
KALV KalVista Pharmaceuticals, A Award deriv2017-03-232017-03-2712,000— $012,000SEC↗
CBYL Carbylan Therapeutics, Inc A Award deriv2015-08-032015-08-0529,000— $029,000SEC↗